Art. 59 Regulation (EU) 2017/745

Derogation from the conformity assessment procedures

In forcesince 24 Apr 2020cited 9×
1.

By way of derogation from Article 52 of this Regulation or, for the period from 24 April 2020 to 25 May 2021, by way of derogation from Article 9(1) and (2) of Directive 90/385/EEC or from Article 11(1) to (6) of Directive 93/42/EEC, any competent authority may authorise, on a duly justified request, the placing on the market or putting into service within the territory of the Member State concerned, of a specific device for which the applicable procedures referred to in those Articles have not been carried out but use of which is in the interest of public health or patient safety or health.

2.

The Member State shall inform the Commission and the other Member States of any decision to authorise the placing on the market or putting into service of a device in accordance with paragraph 1 where such authorisation is granted for use other than for a single patient.

The Member State may inform the Commission and the other Member States of any authorisation granted in accordance with Article 9(9) of Directive 90/385/EEC or Article 11(13) of Directive 93/42/EEC before 24 April 2020.

3.

Following a notification pursuant to paragraph 2 of this Article, the Commission, in exceptional cases relating to public health or patient safety or health, may, by means of implementing acts, extend for a limited period of time the validity of an authorisation granted by a Member State in accordance with paragraph 1 of this Article or, when granted before 24 April 2020, in accordance with Article 9(9) of Directive 90/385/EEC or Article 11(13) of Directive 93/42/EEC to the territory of the Union and set the conditions under which the device may be placed on the market or put into service. Those implementing acts shall be adopted in accordance with the examination procedure referred to in Article 114(3).

On duly justified imperative grounds of urgency relating to the health and safety of humans, the Commission shall adopt immediately applicable implementing acts in accordance with the procedure referred to in Article 114(4).

  • Regulation (EU) 2020/561Lawamends

  • Regulation (EU) 2022/1232728Law

    … временно освобождаване на равнище държави членки съгласно член 59, параграф 1 от Регламент (ЕС) 2017/745 или член 54, параграф 1 от …

  • MPDG790Law

    (1) Unter den in Artikel 59 Absatz 1 der Verordnung (EU) 2017/745 oder in Artikel 54 Absatz 1 der Verordnung (EU) 2017/746 genannten Voraussetzungen kann die zuständige Bundesoberbehörde auf Antrag das Inverkehrbringen oder die …

  • Medizinproduktegesetz 20211283Law

    § 12. (1) Ein Antrag gemäß Art. 59 der Verordnung (EU) Nr. 745/2017 oder Art. 54 der Verordnung (EU) Nr. 746/2017 hat zumindest folgende Angaben zu enthalten: 1. die genaue Bezeichnung des benötigten Medizinproduktes, einschließlich …

  • Gesetz zum Implantateregister Deutschland2Law

    … „Implantat mit Sonderzulassung“ ein Implantat, das mit einer Ausnahmegenehmigung der zuständigen Behörde nach Artikel 59 Absatz 1 der Verordnung (EU) 2017/745 zur Verwendung für eine einzige Patientin oder einen einzigen Patienten …

  • Order of the President of the General Court of 23 February 2022. Atesos medical AG and Others v European Commission.Decision

    23 Feb 2022 · 62021TO0764

  • Order of the President of the General Court of 23 February 2022. Atesos medical AG and Others v European Commission.Decision

    In any event, it should be stated, as the Commission has done, that Article 59(1) of Regulation 2017/745 allows the competent authorities of the Member States to authorise, on a duly justified request, the placing on the market or putting …

    23 Feb 2022 · 62021TO0764

  • MPDG790Law

  • Gesetz zum Implantateregister Deutschland2Law